XY028-133 is a PROTAC-based degrader targeting CDK4/6, designed for anti-tumor activity. Its structure incorporates ligands for von Hippel-Lindau and CDK, facilitating selective protein degradation. This composition enhances its effectiveness in targeted applications.
Usually ships within 24 hours.